Applied Therapeutics
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Employees
- 25
- Market Cap
- -
AT-007 in Adult Subjects With Classic Galactosemia (CG)
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05418829
- Locations
- ๐บ๐ธ
Hassman Research Institute, Berlin, New Jersey, United States
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency
- Conditions
- Hereditary Neuropathy Caused by SORD Deficiency
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT05397665
- Locations
- ๐บ๐ธ
University of Rochester, Rochester, New York, United States
๐บ๐ธUniversity of Miami, Coral Gables, Florida, United States
๐ฎ๐นFondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy
Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT04902781
- Locations
- ๐บ๐ธ
Children's Hospital Colorado, Aurora, Colorado, United States
๐บ๐ธRare Disease Research Center, Atlanta, Georgia, United States
๐บ๐ธUniversity of Michigan, Ann Arbor, Michigan, United States
Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT04117711
- Locations
- ๐บ๐ธ
Anaheim Clinical Trials, LLC, Anaheim, California, United States
๐บ๐ธAtlanta Center for Medical Research, Atlanta, Georgia, United States
๐บ๐ธBrigham and Women's Hospital, Boston, Massachusetts, United States
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
- Conditions
- Diabetic Cardiomyopathies
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Applied Therapeutics, Inc.
- Target Recruit Count
- 675
- Registration Number
- NCT04083339
- Locations
- ๐บ๐ธ
University of California, San Diego (UCSD), La Jolla, California, United States
๐บ๐ธUniversity of California - Irvine Medical Center, Orange, California, United States
๐บ๐ธClinical Trials Research, Lincoln, California, United States